Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Not applicableLooking for participantsNCT04495790
What this trial is testing

AIMS Cancer Outcomes Study

Who this might be right for
NeoplasmsNeoplasm MalignantAdvanced Cancer+2 more
Advanced Integrative Medical Science Institute 500
Early research (Phase 1)Study completedNCT01588548
What this trial is testing

Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma

Who this might be right for
Advanced Solid MalignanciesMalignant Lymphoma
AstraZeneca 43
Testing effectiveness (Phase 2)Ended earlyNCT05219578
What this trial is testing

RTX-224 Monotherapy in Patients With Solid Tumors

Who this might be right for
Non Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more
Rubius Therapeutics 7
Testing effectiveness (Phase 2)Looking for participantsNCT07371663
What this trial is testing

An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors

Who this might be right for
Solid CancersNSCLC (Advanced Non-small Cell Lung Cancer)Gastric (Stomach) Cancer+2 more
Beijing Tide Pharmaceutical Co., Ltd 266
Early research (Phase 1)Study completedNCT04678921
What this trial is testing

Study of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid TumorMetastatic CancerAdvanced Cancer
I-Mab Biopharma US Limited 16
Early research (Phase 1)Looking for participantsNCT07265921
What this trial is testing

A Phase I Study of SIM0609 in Adult Participants With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd. 232
Testing effectiveness (Phase 2)Ended earlyNCT04492033
What this trial is testing

CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Who this might be right for
P1b: Advanced Solid TumorsP2: Biliary Tract Cancer
Handok Inc. 41
Early research (Phase 1)Study completedNCT00908908
What this trial is testing

Determine the Metabolism and Elimination of Carbon-14 Labeled Eribulin Acetate (14C-Eribulin) in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Eisai Inc. 6
Early research (Phase 1)Study completedNCT01977638
What this trial is testing

Phase 1 Trial of CXD101 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Oxford University Hospitals NHS Trust 51
Early research (Phase 1)Ended earlyNCT00311558
What this trial is testing

Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma

Who this might be right for
Cancer
The Cleveland Clinic 18
Early research (Phase 1)Looking for participantsNCT05772455
What this trial is testing

XZB-0004 in Patients With Solid Tumors

Who this might be right for
Advanced Solid TumorNSCLC
Xuanzhu Biopharmaceutical Co., Ltd. 128
Testing effectiveness (Phase 2)Study completedNCT03213678
What this trial is testing

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT02576548
What this trial is testing

MEDI4276 in Adults Subjects With Select HER2-expressing Advanced Solid Tumors.

Who this might be right for
HER2 Expressing Breast or Gastric/Stomach Cancers
MedImmune LLC 47
Testing effectiveness (Phase 2)Study completedNCT01606748
What this trial is testing

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin

Who this might be right for
Malignant Solid Tumor
Eli Lilly and Company 35
Testing effectiveness (Phase 2)UnknownNCT04458389
What this trial is testing

TY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory Lymphomas

Who this might be right for
Locally Advanced /Metastatic Solid TumorsRelapsed or Refractory Lymphomas
Tayu Huaxia Biotech Medical Group Co., Ltd. 268
Testing effectiveness (Phase 2)Study completedNCT02810418
What this trial is testing

Mesothelin-Targeted Immunotoxin LMB-100 Alone or in Combination With Nab-Paclitaxel in People With Previously Treated Metastatic and/or Locally Advanced Pancreatic Ductal Adenocarcinoma and Mesothelin Expressing Solid Tumors

Who this might be right for
NeoplasmsPancreatic Neoplasms
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07615660
What this trial is testing

Clinical Study of CVL006 Combination With 9MW2821

Who this might be right for
Advanced Solid Tumor
Convalife (Shanghai) Co., Ltd. 108
Not applicableUnknownNCT04548960
What this trial is testing

OncoSNIPE - Study of Molecular Profiles Associated With the Development of Resistance in Solid Cancer Patients

Who this might be right for
CANCER
Oncodesign SA 600
Early research (Phase 1)UnknownNCT01724320
What this trial is testing

A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 20
Next Page